Human hypertension is characterized by a lack of activation of the antihypertensive cardiac hormones ANP and BNP.
about
Angiotensin receptor neprilysin inhibitor LCZ696: a novel targeted therapy for arterial hypertension?Neutral endopeptidase inhibition and the natriuretic peptide system: an evolving strategy in cardiovascular therapeuticsINTERACTING DISCIPLINES: Cardiac natriuretic peptides and obesity: perspectives from an endocrinologist and a cardiologistInnovative Therapeutics: Designer Natriuretic Peptides.Cardiac BNP gene delivery prolongs survival in aged spontaneously hypertensive rats with overt hypertensive heart disease.Cardiac Natriuretic Peptides, Hypertension and Cardiovascular RiskHigher serum concentrations of N-terminal pro-B-type natriuretic peptide associate with prevalent hypertension whereas lower associate with incident hypertension.The regulation of troponins I, C and ANP by GATA4 and Nkx2-5 in heart of hibernating thirteen-lined ground squirrels, Ictidomys tridecemlineatus.Circulating atrial natriuretic peptide genetic association study identifies a novel gene cluster associated with stroke in whites.Increasing aminoterminal-pro-B-type natriuretic peptide precedes the development of arterial hypertension: the multiethnic study of atherosclerosisB-Type Natriuretic Peptide Deletion Leads to Progressive Hypertension, Associated Organ Damage, and Reduced Survival: Novel Model for Human Hypertension.Efficacy of B-Type Natriuretic Peptide Is Coupled to Phosphodiesterase 2A in Cardiac Sympathetic Neurons.Beneficial Effects of Combined AT1 Receptor/Neprilysin Inhibition (ARNI) Versus AT1 Receptor Blockade Alone in the Diabetic Eye.C-type natriuretic peptide and natriuretic peptide receptor B signalling inhibits cardiac sympathetic neurotransmission and autonomic functionA functional genetic variant (N521D) in natriuretic peptide receptor 3 is associated with diastolic dysfunction: the prevalence of asymptomatic ventricular dysfunction study.M-atrial natriuretic peptide and nitroglycerin in a canine model of experimental acute hypertensive heart failure: differential actions of 2 cGMP activating therapeutics.Natriuretic peptides in cardiometabolic regulation and disease.Natriuretic Peptides as a Novel Target in Resistant Hypertension.Angiotensin receptor neprilysin inhibitor LCZ696: pharmacology, pharmacokinetics and clinical development.Attenuation of monocyte chemotaxis--a novel anti-inflammatory mechanism of action for the cardio-protective hormone B-type natriuretic peptide.Targeting Obesity and Diabetes to Treat Heart Failure with Preserved Ejection Fraction.Mid-regional pro-atrial natriuretic peptide and blood pressure in adolescents: effect of gender and pubertal stage.Transport stress induces apoptosis in rat myocardial tissue via activation of the mitogen-activated protein kinase signaling pathways.Serum proatrial natriuretic peptide does not increase with higher systolic blood pressure in obese men.Renal papillary tip extract stimulates BNP production and excretion from cardiomyocytes.Using predicate and provenance information from a knowledge graph for drug efficacy screening
P2860
Q26741084-A7585493-D560-49E5-A726-B53E6651E22CQ27004000-926B1069-48BE-4978-83F6-41565DD9F810Q28083473-B3AFE850-9C72-48B1-AD7C-8B6359E39DD7Q33653332-4E90DFF1-7C3F-488C-B032-CA9726081997Q33657331-1B65D63E-A7FA-4789-B9DA-E60B4B7C944CQ33715302-DBBBB30E-758D-49D3-A461-747F99DBE918Q35058920-A95F1014-FFB2-46D3-A0F1-D44D890F55EFQ35101663-D9A13C24-08E2-4221-AB92-9808F4389E14Q35294797-77D55454-B5B1-4996-9F33-690EEB27541DQ35540503-56D83CB1-D003-4CEC-AD2A-84286CD267DBQ35742577-E778A6D6-46EB-4D99-A7DE-67EE5DC68967Q35806196-C4B04E4F-ACA9-4D59-8BD2-8A9FF32BB070Q37503374-F957CDC6-D072-4250-B79C-4114934F3C8EQ37505040-C12DEC65-2928-4FB4-B1AF-AAFDEF244BECQ37505066-222E0C25-3E4E-4B38-A663-D7C137DE1A14Q37648508-F7045F08-1888-409E-9069-B8CD77BDC7ADQ38211333-F757D2F4-A147-4803-BB21-D4ECD8214779Q38371173-7AE999A6-B6CF-402E-853A-C8152CD49FABQ38790076-8733399E-858C-451B-8B3E-5D7B91016809Q39159036-B6A7331F-93B4-4EC3-82CD-DC34B14EF74CQ41025346-D1D1C3DD-B298-4440-8FB3-AE3F9DF2A0F6Q41742263-8263A2E6-10B0-41CD-9534-F2CCDAD4D660Q48436027-8A912A8E-97A1-411F-8FE2-6654B1748124Q51280778-3C5A39F9-F12F-4FCC-8C3A-23C02255643FQ54938378-8C014F86-939D-4117-B39C-42A3A6C20E6BQ58761782-054BA72C-ECFD-42AB-BCEF-E914E198CD7C
P2860
Human hypertension is characterized by a lack of activation of the antihypertensive cardiac hormones ANP and BNP.
description
2012 nî lūn-bûn
@nan
2012 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
name
Human hypertension is characte ...... cardiac hormones ANP and BNP.
@ast
Human hypertension is characte ...... cardiac hormones ANP and BNP.
@en
type
label
Human hypertension is characte ...... cardiac hormones ANP and BNP.
@ast
Human hypertension is characte ...... cardiac hormones ANP and BNP.
@en
prefLabel
Human hypertension is characte ...... cardiac hormones ANP and BNP.
@ast
Human hypertension is characte ...... cardiac hormones ANP and BNP.
@en
P2093
P2860
P1476
Human hypertension is characte ...... cardiac hormones ANP and BNP.
@en
P2093
Alessandro Cataliotti
Christopher G Scott
Denise Heublein
Diego Bellavia
Fima Macheret
Guido Boerrigter
Horng H Chen
John Burnett
Kent Bailey
Lisa C Costello-Boerrigter
P2860
P304
P356
10.1016/J.JACC.2012.05.049
P407
P577
2012-10-01T00:00:00Z